Search Results 3531-3540 of 26225 for oral

  1. Allergic Diseases - Clinical trials

    ... oral antibiotics, topical antibiotics, oral corticosteroids, topical corticosteroids, leukotriene receptor antagonist, and interleukin 5 receptor ...

  2. A Study to Evaluate if Benralizumab Compared to Mepolizumab May be Beneficial in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) - Mayo Clinic

    ... oral corticosteroid (OCS) dose ≤ 7.5 mg/day of prednisolone or equivalent, following standard induction regimen for at least 3 months and within 6 months ...

  3. Visiting the dentist saves money, reduces likelihood of hospitalization for people with diabetes or coronary artery disease - Mayo Clinic News Network

    Physicians and dentists know that oral health is a critical element of overall health. However, there are many unknowns with respect to the effects of ...

  4. Radial vs. State-Of-The-Art Femoral Access for Bleeding and Access Site Complication Reduction in Cardiac Catheterization (REBIRTH) - Mayo Clinic

    ... oral factor Xa or IIa inhibitors ≤ 24 h before procedure - Planned staged PCI within 30 days after index procedure. - Any planned surgeries within 30 days ...

  5. HPV infection - Symptoms & causes - Mayo Clinic

    Oral and upper respiratory sores, called lesions. Some HPV infections cause lesions on the tongue, tonsils or soft palate, or within the larynx and nose.

  6. Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II - Mayo Clinic

    ... oral anticoagulant 21. Comorbidities limiting life expectancy to less than one year 22. Subject is currently hospitalized for definite or suspected COVID-19

  7. After Facial Surgery, Tammy Says Goodbye to Years of Sleep Apnea - Mayo Clinic News Network

    After meeting Christopher Viozzi, M.D., D.D.S., a Mayo Clinic oral and maxillofacial surgeon, however, Tammy found the help she so desperately needed. Tammy ...

  8. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric and Adolescent Medicine · Pediatric Otolaryngology · Physical Medicine ...

  9. A Study of LOXO-292 in Patients with Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer - Mayo Clinic

    ... orally to patients with advanced solid tumors, including RET-fusion-positive solid tumors, medullary thyroid cancer (MTC) and other tumors with RET activation.

  10. IXAZOMIB Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Newly Diagnosed Multiple Myeloma - Mayo Clinic

    ... oral absorption or tolerance of treatment; Treatment with any investigational products within 60 days before the first dose of the study drug regimen ...